Biomatrix Alpha Drug Eluting Coronary Stent System - Vietnam Registration 50318

Access comprehensive regulatory information for Biomatrix Alpha Drug Eluting Coronary Stent System in Vietnam's medical device market through Pure Global AI's free database. is registered under number 50318 and manufactured by Biosensors Interventional Technologies Pte. Ltd.. The authorized representative in Vietnam is CPC1 Central Pharmaceutical Joint Stock Company.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.